Aquestive Therapeutics, Inc. AQST Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s total equity?
- Aquestive Therapeutics, Inc. (AQST) reported total equity of -$34.05M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s total equity changed year-over-year?
- Aquestive Therapeutics, Inc.'s total equity increased by 44.1% year-over-year, from -$60.93M to -$34.05M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total equity has grown at a -7.0% compound annual growth rate (CAGR), from -$48.5M to -$33.66M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.